olmesartan has been researched along with Kidney Failure, Chronic in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhakta, K; Brewer, ED; Cotton, RT; Galvan, NTN; Geha, JA; Geha, JD; Goss, JA; Goss, M; Kueht, ML; O'Mahony, CA; Rana, A; Swartz, SJ | 1 |
| Higa, A; Hirano, H; Iseki, K; Kohagura, K; Shiohira, Y; Tokuyama, K; Toma, S; Ueda, S | 1 |
| Ishida, A; Ito, O; Kanazawa, M; Kohzuki, M; Kurosawa, H; Lu, H; Ootaka, T; Sasaki, Y; Sato, T; Tufescu, A | 1 |
| Baylis, C; Moningka, NC; Sasser, JM; Tsarova, T | 2 |
| Amaha, M; Kawagoe, Y; Maeda, S; Nakamura, T; Sato, E; Yamagishi, S | 1 |
| Chan, JC; Haneda, M; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T | 1 |
| Imai, E | 1 |
| Chuang, YC; Fang, KM; Su, YK; Wu, MS | 1 |
| Halimi, S | 1 |
| Hiramatsu, N; Hiromura, K; Ideura, H; Ikeuchi, H; Kaneko, Y; Kopp, JB; Kuroiwa, T; Nojima, Y; Sakurai, N; Shigehara, T; Takeuchi, S; Tomioka, M; Ueki, K | 1 |
| Chan, JC; Haneda, M; Imai, E; Ito, S; Makino, H | 1 |
| Anraku, M; Gebicki, JM; Kadowaki, D; Kitamura, K; Maruyama, T; Otagiri, M; Tasaki, Y; Tomita, K; Wakamatsu, S | 1 |
| Fukuda, M; Kimura, G; Miyagi, S; Mizuno, M; Motokawa, M; Nishio, T; Shirasawa, Y; Yamanaka, T; Yoshida, A | 1 |
1 review(s) available for olmesartan and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Primary cardiorenal prevention in patients with type-2 diabetes. The Roadmap study].
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Imidazoles; Incidence; Kidney Failure, Chronic; Male; Meta-Analysis as Topic; Metabolic Syndrome; Multicenter Studies as Topic; Placebos; Primary Prevention; Randomized Controlled Trials as Topic; Rats; Rats, Inbred Strains; Risk Factors; Sex Factors; Tetrazoles; Time Factors; Treatment Outcome | 2005 |
7 trial(s) available for olmesartan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Olmesartan clinical trial in Okinawan patients under OKIDS (OCTOPUS) study: design and methods.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension, Renal; Imidazoles; Japan; Kidney Failure, Chronic; Renal Dialysis; Tetrazoles | 2009 |
Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria.
Topics: Adult; Amides; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Fatty Acid-Binding Proteins; Female; Fumarates; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Tubules; Male; Proteinuria; Regression Analysis; Tetrazoles | 2012 |
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Stroke; Tetrazoles; Treatment Outcome | 2011 |
[Series: Clinical study from Japan and its reflections; Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy Trial (ORIENT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Imidazoles; Kidney Failure, Chronic; Male; Tetrazoles | 2011 |
Olmesartan reducing incidence of endstage renal disease in diabetic nephropathy trial (ORIENT): rationale and study design.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Asian People; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Imidazoles; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Research Design; Tetrazoles | 2006 |
Effect of olmesartan on oxidative stress in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Blood Pressure; Female; Humans; Hypertension, Renal; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peroxides; Placebos; Renal Dialysis; Serum Albumin; Tetrazoles; Uremia | 2007 |
Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Natriuresis; Sodium; Tetrazoles | 2008 |
6 other study(ies) available for olmesartan and Kidney Failure, Chronic
| Article | Year |
|---|---|
Successful kidney transplantation in a small child with end-stage renal disease due to angiotensin receptor blocker fetopathy and atretic inferior vena cava.
Topics: Allografts; Anastomosis, Surgical; Angiotensin Receptor Antagonists; Aorta; Child, Preschool; Humans; Iliac Vein; Imidazoles; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Pediatrics; Postoperative Period; Renal Veins; Tetrazoles; Thrombosis; Vascular Grafting; Vena Cava, Inferior; Venous Thrombosis | 2019 |
Combination of chronic exercise and antihypertensive therapy enhances renoprotective effects in rats with renal ablation.
Topics: Ablation Techniques; Actins; Animals; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Urea Nitrogen; Combined Modality Therapy; Creatinine; Dihydropyridines; Exercise Therapy; Imidazoles; Kidney; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Inbred WKY; Tetrazoles | 2009 |
Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Benzopyrans; Blotting, Western; Enzyme Inhibitors; Ethanolamines; Hydrogen Peroxide; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Superoxide Dismutase; Tetrazoles | 2012 |
Effects of olmesartan on arterial stiffness in rats with chronic renal failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Aorta; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Glycation End Products, Advanced; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Kidney Failure, Chronic; Male; Malondialdehyde; Nephrectomy; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazoles; Vascular Stiffness | 2012 |
Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzopyrans; Blotting, Western; Chromatography, High Pressure Liquid; Disease Models, Animal; Ethanolamines; Imidazoles; Infarction; Kidney Cortex; Kidney Failure, Chronic; Male; Nebivolol; Rats; Rats, Sprague-Dawley; Tetrazoles | 2012 |
Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model.
Topics: AIDS-Associated Nephropathy; Angiotensin II Type 1 Receptor Blockers; Animals; Black People; Disease Models, Animal; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Failure, Chronic; Membrane Proteins; Mice; Mice, Transgenic; Receptor, Angiotensin, Type 1; Tetrazoles | 2007 |